Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism.

Autor: Deprince, Audrey, Hennuyer, Nathalie, Kooijman, Sander, Pronk, Amanda C. M., Baugé, Eric, Lienard, Viktor, Verrijken, An, Dirinck, Eveline, Vonghia, Luisa, Woitrain, Eloïse, Kloosterhuis, Niels J., Marez, Eléonore, Jacquemain, Pauline, Wolters, Justina C., Lalloyer, Fanny, Eberlé, Delphine, Quemener, Sandrine, Vallez, Emmanuelle, Tailleux, Anne, Kouach, Mostafa

Publikováno v: Hepatology (02709139); Apr2023, Vol. 77 Issue 4, p1287-1302, 16p

Author Correction: Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution.

Autor: Haas JT; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France., Vonghia L; Department of Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium. luisa.vonghia@uza.be.; Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. luisa.vonghia@uza.be., Mogilenko DA; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France., Verrijken A; Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.; Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium., Molendi-Coste O; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France., Fleury S; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France., Deprince A; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France., Nikitin A; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France., Woitrain E; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France., Ducrocq-Geoffroy L; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France., Pic S; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France., Derudas B; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France., Dehondt H; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France., Gheeraert C; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France., Van Gaal L; Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.; Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium., Driessen A; Department of Pathology, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium., Lefebvre P; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France., Staels B; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France., Francque S; Department of Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium.; Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium., Dombrowicz D; University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011-EGID, Lille, France. david.dombrowicz@pasteur-lille.fr.

Publikováno v: Nature metabolism [Nat Metab] 2019 Jul; Vol. 1 (7), pp. 744.